Assertio therapeutics announces first-quarter 2020 results

Assertio therapeutics announces first-quarter 2020 results.assertio therapeutics - merger with zyla life sciences on track, expected to close shortly after co's 2020 annual meeting.assertio therapeutics - qtrly total revenues $20.9 million versus $57.9 million.assertio therapeutics - qtrly earnings per share $0.58.assertio therapeutic - could see negative impact in product sales during peak of pandemic, which is expected to be in q2.assertio therapeutics - due to covid-19, co will not be providing guidance.assertio therapeutics - covid-19 did not have material adverse effect on reported results for q1.
ASRT Ratings Summary
ASRT Quant Ranking